Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation

Litton, JK; Rugo, HS; Ettl, J; Hurvitz, SA; Goncalves, A; Lee, KH; Fehrenbacher, L; Yerushalmi, R; Mina, LA; Martin, M; Roche, H; Im, YH; Quek, RGW; Markova, D; Tudor, IC; Hannah, AL; Eiermann, W; Blum, JL

Litton, JK (reprint author), Univ Texas MD Anderson Canc Ctr, Breast Med Oncol, 1515 Holcombe Blvd,Unit 1354, Houston, TX 77030 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2018; 379 (8): 753

Abstract

BACKGROUND The poly(adenosine diphosphate-ribose) inhibitor talazoparib has shown antitumor activity in patients with advanced breast cancer and germl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索